cere 120 tries again
 

Phase 1/2 Trial Assessing the Safety and Efficacy of Bilateral Intraputaminal and Intranigral Administration of CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) in Subjects With Idiopathic Parkinson's Disease
OR
Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease

open label

see: http://clinicaltrials.gov/ct2/show/N...urturin&rank=1
Curently recruiting at :
United States, New York
Mount Sinai Medical Center

United States, Georgia
Emory University
Not yet recruiting
Atlanta, Georgia, United States
Principal Investigator: Nicholas M. Boulis, M.D.
Sub-Investigator: Mahlon R. DeLong, M.D

There aren't enough slots for all of the sham surgery participants but the first up is a forum member who got sham surgery first time around.

I was told the previous sham participants in the phase 2 were not eligible for this new cere-120 trial. Maybe something has changed since then.

requalified
 

Hi Todd,

This patient had to requalify for the trial. He could not score over or under the measurement criteria for the trial. He was persistent and did qualify according to the new standards.

Duke is the second hospital Cere-120
 

Hello. Duke medical center is the second hospital to do the surgery. I was the second candidate(scars healing). Anybody know the first guy? I would like to contact him....